Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Neurofibromatosis 2018 NINDS 5R35NS097211-02 Defining the Mechanistic Basis for Neurofibromatosis-1 Nervous System Disease Heterogeneity GUTMANN, DAVID WASHINGTON UNIVERSITY MO $684,641
Neurofibromatosis 2018 NCI 5R01CA111754-13 Elucidating the Regulation and Function of the NF1 tumor suppressor CICHOWSKI, KAREN BRIGHAM AND WOMEN'S HOSPITAL MA $316,635
Neurofibromatosis 2018 NCI 5R01CA142928-09 Targeting the Kinome in Neurofibromatosis type 1 CHERNOFF, JONATHAN RESEARCH INST OF FOX CHASE CAN CTR PA $434,625
Neurofibromatosis 2018 NCI 5R01CA072597-19 Oncogenic Events in Thyroid Neoplasia FAGIN, JAMES SLOAN-KETTERING INST CAN RESEARCH NY $428,500
Neurofibromatosis 2018 NHLBI 5R01HL127339-04 The role of NF2 in myocardial ischemia and reperfusion injury DELRE, DOMINIC RBHS-NEW JERSEY MEDICAL SCHOOL NJ $397,500
Neurofibromatosis 2018 NINDS 5R01NS086938-05 Function & regulation of Hippo pathway effectors YAP/TAZ during brain development CAO, XINWEI ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $382,813
Neurofibromatosis 2018 NIDCD 5U01DC013030-05 Phase I safety study for a new two-shank auditory midbrain implant (AMI) LIM, HUBERT UNIVERSITY OF MINNESOTA MN $281,793
Neurofibromatosis 2018 NINDS 5R01NS091037-04 Brain Dysfunction in Neurofibromatosis RATNER, NANCY CINCINNATI CHILDRENS HOSP MED CTR OH $309,792
Neurofibromatosis 2018 NCI 5R35CA197709-03 New Ways of Targeting K-Ras MCCORMICK, FRANK UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $944,270
Neurofibromatosis 2018 NINDS 5R01NS097237-02 Mechanisms of Nf1 pathophysiology underlying hyperactivity TOMCHIK, SETH SCRIPPS FLORIDA FL $415,625
Neurofibromatosis 2018 NINDS 5R01NS034783-20 Function of NF2/Merlin in regulation of the Hippo/Salvador/Warts growth control pathway FEHON, RICHARD UNIVERSITY OF CHICAGO IL $493,194
Neurofibromatosis 2018 NCI 1R01CA227807-01 Genomics and Functional Characterization of NF1-mutated Lung Cancer COLLISSON, ERIC UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $554,851
Neurofibromatosis 2018 NINDS 1R21NS105941-01 Development and validation of small molecules to treat neurofibromatosis associated schwannoma KISSIL, JOSEPH SCRIPPS FLORIDA FL $475,000
Neurofibromatosis 2018 NINDS 5R01NS097233-03 miR-155 and RUNX function in neurofibroma tumorigenesis and therapy WU, JIANQIANG CINCINNATI CHILDRENS HOSP MED CTR OH $341,250
Neurofibromatosis 2018 NINDS 5R01NS095411-04 Targeting Tumors with NF1 Loss SANCHEZ, YOLANDA DARTMOUTH COLLEGE NH $541,146
Neurofibromatosis 2018 NINDS 5R21NS099417-02 Development and validation of a genetically engineered model of neurofibromatosis type 2 to facilitate discovery of neurotherapeutics KISSIL, JOSEPH SCRIPPS FLORIDA FL $429,848
Neurofibromatosis 2018 NCI 5R01CA201130-03 Phase II trial of mTORC1/mTORC2 inhibitor AZD2014 for sporadic meningioma RAMESH, VIJAYA MASSACHUSETTS GENERAL HOSPITAL MA $401,040
Neurofibromatosis 2018 NINDS 5R01NS086219-05 Disordered Regulation of Wnt/beta-catenin Signaling in MPNST Development and Maintenance LARGAESPADA, DAVID UNIVERSITY OF MINNESOTA MN $496,936
Neurofibromatosis 2018 NICHD 5R01HD089474-03 Neurobiology and Treatment of Reading Disability in NF1 CUTTING, LAURIE VANDERBILT UNIVERSITY TN $623,293
Neurofibromatosis 2018 NIDCD 1F31DC016528-01A1 A Novel Approach to Treating Sensorineural Hearing loss and Inner Ear Disease in Neurofibromatosis Type 2 (NF2) HAWLEY, ERIC INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $28,794
Neurofibromatosis 2018 NCI 5R01CA214146-03 DEFINING RISK FACTORS FOR NF1-OPTIC GLIOMA GUTMANN, DAVID WASHINGTON UNIVERSITY MO $348,844
Neurofibromatosis 2018 NIAMS 1R21AR072483-01A1 Matrix-Sensitive Tools for Detecting NF1-Related Changes in Bone Quality NYMAN, JEFFRY VANDERBILT UNIVERSITY MEDICAL CENTER TN $232,059
Neurofibromatosis 2018 NCI 5U01CA202943-03 Developing a translational pipeline for NF1-mutant malignancies CICHOWSKI, KAREN BRIGHAM AND WOMEN'S HOSPITAL MA $235,046
Neurofibromatosis 2018 NINDS 5R01NS028840-27 Mitogenic Activities in Neurofibromatosis RATNER, NANCY CINCINNATI CHILDRENS HOSP MED CTR OH $445,976
Neurofibromatosis 2018 NCI 5U54CA196519-04 7036 Core A: Omics Core JOHNSON, GARY UNIV OF NORTH CAROLINA CHAPEL HILL NC $215,189
Neurofibromatosis 2018 NCI 5U54CA196519-04 7037 Core B: Biospecimen/Pathology Core FOROUD, TATIANA INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $113,645
Neurofibromatosis 2018 NCI 5U54CA196519-04 7038 Core C: Administrative Core CLAPP, DAVID INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $47,766
Neurofibromatosis 2018 NCI 5U54CA196519-04 7039 Project 1: Molecular and Genetic Features Across Mouse and Human Plexiform Neurofibromas to Inform Clinical Trials CLAPP, DAVID INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $123,492
Neurofibromatosis 2018 NCI 5U54CA196519-04 7040 Project 2: Targeted Therapies for Malignant Peripheral Nerve Sheath Tumors SKAPEK, STEPHEN UT SOUTHWESTERN MEDICAL CENTER TX $439,640
Neurofibromatosis 2018 NCI 5U54CA196519-04 7041 Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia SHANNON, KEVIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $425,561
Neurofibromatosis 2018 NCI 5U54CA196519-04 7042 Project 4: Secondary Cancers Among NF1 Cancer Survivors NAKAMURA, JEAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $521,291
Neurofibromatosis 2018 NCI 5U54CA196519-04 7043 Developmental Research Program SHANNON, KEVIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $119,512
Neurofibromatosis 2018 NCI 5U54CA196519-04 7044 Career Development Program SHANNON, KEVIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $95,959
Neurofibromatosis 2018 NIDCD 5R01DC015824-03 Mechanisms of sensorineural hearing loss: secreted factors STANKOVIC, KONSTANTINA MASSACHUSETTS EYE AND EAR INFIRMARY MA $425,000
Neurofibromatosis 2018 NINDS 5R37NS096359-03 Molecular and signaling mechanisms of peripheral nerve sheath tumorigenesis LU, QING CINCINNATI CHILDRENS HOSP MED CTR OH $529,965
Neurofibromatosis 2018 NICHD 5F31HD089606-02 Social Competence in Youth with Neurofibromatosis Type 1 MCCURDY, MARK DREXEL UNIVERSITY PA $44,524
Neurofibromatosis 2018 NIDCD 1R01DC017264-01 Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas FERNANDEZ-VALLE, CRISTINA UNIVERSITY OF CENTRAL FLORIDA FL $637,684
Neurofibromatosis 2018 NCI 1K99CA230312-01 ARF6 function in cancers driven by RAS hyperactivation YOO, JAE HYUK UNIVERSITY OF UTAH UT $129,824
Neurofibromatosis 2018 NCI 2R01CA166593-06A1 Cell of Origin and the Roles of Tumor Microenvironment in Neurofibroma Development and Therapeutics LE, LU UT SOUTHWESTERN MEDICAL CENTER TX $384,750
Neurofibromatosis 2018 NCATS 2R42CA192600-02 Cloud quantitative imaging for whole-body tumor burden in neurofibromatoses WU, YIN IQ MEDICAL IMAGING, LLC MA $556,344
Neurofibromatosis 2018 NCI 2R42CA192600-02 Cloud quantitative imaging for whole-body tumor burden in neurofibromatoses WU, YIN IQ MEDICAL IMAGING, LLC MA $184,073
Neurofibromatosis 2018 NCI 1R50CA233164-01 Developing Human Induced Pluripotent Stem Cell Precision Oncology Models ANASTASAKI, CORINA WASHINGTON UNIVERSITY MO $155,981
Neurofibromatosis 2018 NINDS 3R01NS097237-02S1 Mechanisms of Nf1 pathophysiology underlying hyperactivity TOMCHIK, SETH SCRIPPS FLORIDA FL $31,091
Neurofibromatosis 2018 NINDS 1R56NS102254-01A1 Co-targeting FAK and PI3K for NF2 Schwannomas FERNANDEZ-VALLE, CRISTINA UNIVERSITY OF CENTRAL FLORIDA FL $462,161
Neurofibromatosis 2018 NINDS 1R01NS104489-01A1 F-box ubiquitin ligases destabilize neurofibromin CLAPP, DAVID INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $344,531
Neurofibromatosis 2018 NIDCD 1F31DC017047-01A1 Identification of Novel Small Molecule Inhibitors for Vestibular Schwannoma and NF2 SAGERS, JESSICA HARVARD MEDICAL SCHOOL MA $32,211
Neurofibromatosis 2018 NINDS 1R21NS106135-01A1 Neurophysiological and neuroanatomical processes related to Autism Spectrum Disorder in Neurofibromatosis Type 1 HOCKING, MATTHEW CHILDREN'S HOSP OF PHILADELPHIA PA $215,000
Neurofibromatosis 2018 NINDS 1R13NS110303-01 2018 Joint Global Neurofibromatosis Conference MESSIAEN, LUDWINE CHILDREN'S TUMOR FOUNDATION NY $10,000
Neurofibromatosis 2018 NINDS 4R37NS083580-05 Ras Proteins in Nerve Tumorigensis RATNER, NANCY CINCINNATI CHILDRENS HOSP MED CTR OH $397,500
Neurofibromatosis 2018 NIDCD 3R01DC015824-02S1 Mechanisms of sensorineural hearing loss: secreted factors STANKOVIC, KONSTANTINA MASSACHUSETTS EYE AND EAR INFIRMARY MA $59,500
Neurofibromatosis 2018 NCI 1ZIACP010144-20 Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes PEMOV, ALEXANDER NIH $7,969,561
Neurofibromatosis 2018 NCI 1ZIABC010801-12 Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes WIDEMANN, BRIGITTE NIH $1,367,242
Neurofibromatosis 2018 NCI 1ZIABC011470-07 Development of Natural Product Leads as Anticancer Therapeutics BEUTLER, JOHN NIH $466,064
Neurofibromatosis 2018 NCI 1ZIABC011734-03 Genomic dissection of tumor heterogeneity and progression SHERN, JOHN NIH $551,809
Neurofibromatosis 2018 NCI 1ZIABC011754-02 Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1 REILLY, KARLYNE NIH $1,024,981
Neurofibromatosis 2018 NCI 1ZIDBC011517-06 Pediatric Oncology Branch Behavioral Science Core GLOD, JOHN NIH $1,220,331
Neurofibromatosis 2018 NINDS 1ZIANS003132-07 Neurooncology of Benign Central and Peripheral Nervous System Tumors HEISS, JOHN NIH $690,950
Neurofibromatosis 2018 NINDS 1ZIANS003053-11 Neuro-oncology of Familial Neoplasia Syndromes YOULE, RICHARD NIH $771,143
Neurofibromatosis 2018 NEI 1ZIAEY000388-17 Neuro-ophthalmic Mechanisms Of Disease FITZGIBBON, EDMOND NIH $269,363


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer